STOCK TITAN

Societal to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Societal CDMO (SCTL) has announced participation in three upcoming investor conferences, aimed at showcasing its capacity as a contract development and manufacturing organization. The conferences include the H.C. Wainwright Global Investment Conference from May 23-25, 2022; the 19th Annual Craig-Hallum Institutional Investors Conference on June 1, 2022; and the William Blair 42nd Annual Growth Stock Conference from June 6-9, 2022. Notably, Societal CDMO specializes in small molecule therapeutic development and offers comprehensive manufacturing solutions.

Positive
  • None.
Negative
  • None.

SAN DIEGO and GAINESVILLE, Ga., May 19, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that the company will participate in three upcoming investor conferences.

Details of the company’s participation are as follows:

  • H.C. Wainwright Global Investment Conference
    Details: Societal management will deliver a corporate presentation and participate in 1-on-1 meetings
    Conference Dates: May 23-25, 2022
    Presentation Timing: Available online at 7:00 a.m. Eastern on Tuesday, May 24, 2022
    Format: Hybrid conference (in person and virtual)
  • 19th Annual Craig-Hallum Institutional Investors Conference
    Details: Societal management will participate in 1-on-1 meetings
    Conference Dates: June 1, 2022
    Format: Virtual conference
  • William Blair 42nd Annual Growth Stock Conference
    Details: Societal management will deliver a corporate presentation and participate in 1-on-1 meetings
    Conference Dates: June 6-9, 2022
    Presentation Timing: 8:40 a.m. Central on Wednesday, June 8, 2022
    Format: In person conference (Chicago, IL); webcast available

To access the webcast of the William Blair presentation, please visit the “Events” page in the Investor section of the Company’s website, www.societalcdmo.com. The webcasts will be archived on the Company’s website for 30 days.

About Societal CDMO
Societal CDMO (NASDAQ: SCTL) is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal CDMO is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market.

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, which total 145,000 square feet, in Gainesville, Georgia and San Diego, California.

Societal CDMO: Bringing Science to Society. For more information about Societal CDMO’s customer solutions, visit societalcdmo.com.


FAQ

When is Societal CDMO participating in the H.C. Wainwright Global Investment Conference?

Societal CDMO will participate in the H.C. Wainwright Global Investment Conference from May 23-25, 2022.

What type of presentation will Societal CDMO give at the William Blair Conference?

Societal CDMO will deliver a corporate presentation and participate in 1-on-1 meetings at the William Blair Conference from June 6-9, 2022.

What are the details for the 19th Annual Craig-Hallum Conference?

The 19th Annual Craig-Hallum Institutional Investors Conference will be held on June 1, 2022, and will consist of 1-on-1 meetings.

Where can I access the webcast of the William Blair presentation?

The webcast of the William Blair presentation can be accessed on the Investor section of Societal CDMO's website.

What expertise does Societal CDMO offer in pharmaceutical development?

Societal CDMO specializes in small molecule therapeutic development, providing end-to-end regulatory support, clinical and commercial manufacturing, and more.

Societal CDMO, Inc.

NASDAQ:SCTL

SCTL Rankings

SCTL Latest News

SCTL Stock Data

116.13M
57.79M
45.32%
57.56%
0.26%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Exton